Tus kws kho mob
QP82-18 Pharmacy Benefit Exclusion for Azedra (iobenguane I 131) Intravenous Injection
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 28, 2018
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2351 - 2360 ntawm 4374
Tus kws kho mob
QP86-18 Addition of Drug to the Calcitonin Gene-Related Peptide (CGRP) Prior Authorization with Quantity Limit Program
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 14, 2018
Tus kws kho mob
QP70-18 Pharmacy Benefit Exclusion for Alferon N (interferon alpha-n3) and Lanoxin (digoxin) Injection for Minnesota Health Care Programs Subscribers
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 21, 2018
Tus kws kho mob
QP35-17 Implementation of New Utilization Management Platform
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 07, 2017
Tus kws kho mob
QP85-18 Pharmacy Benefit Update - New Drug-Related PA with QL Criteria: Pseudobulbar Affect (PBA)
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 11, 2018
Tus kws kho mob
QP99-18 New FEP Employee Opioid Prescription Requirements
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 28, 2018
Tus kws kho mob
QP66-18 Pharmacy Benefit Update - New Drug-Related Prior Authorization with Quantity Limit Criteria: Noctiva (desmopressin acetate)
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 21, 2018
Tus kws kho mob
QP16-17 Contract Renewal Overlapping with Termination Notices for Interpreter Agencies
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 20, 2017
Tus kws kho mob
QP20-17 Searching Eligibility and Benefits
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 08, 2017
Tus kws kho mob
QP68-18 Site of Care Drug Infusion/Injection Program
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 21, 2018